Search bioRxiv⌕ Search

Biology subjects

Sewgoolam, B.

Publications and source records attributed to Sewgoolam, B..

2 recordsLinked to original sources

A functional genetic landscape of antibiotic sensitivity across the pneumococcal pangenome reveals conserved and lineage-specific vulnerabilities

The large pangenome of Streptococcus pneumoniae enables this opportunistic pathogen to adapt and evade antibiotic treatment. Effective treatment of pneumococcal infections requires a better understanding of the genes that modulate susceptibility to antibiotics across the pangenome. Using CRISPRi-seq, we identified genes that contribute to antibiotic sensitivity against a panel of clinically relevant antibiotics across nine pneumococcal strains with diverse resistance profiles, serotypes, and lineages. The here-generated chemical-genetics atlas revealed distinct genome-wide signatures of antibiotic stress that were specific to the antibiotic mode of action and showed both strain-specific and conserved signatures. This allowed us to identify conserved genes involved in antibiotic vulnerability and assign functions to previously uncharacterized genes. For instance, deletion of mutS2, which may act as a ribosome collision sensor and spv_1295, a conserved gene of unknown function, resulted in increased sensitivity to the macrolide azithromycin across strains, including a macrolide resistant strain, and could be potential targets for global sensitizing therapies. This work establishes a pangenome-wide framework for understanding antibiotic stress responses in S. pneumoniae, providing a foundation for the rational development of therapies that exploit conserved and strain-specific vulnerabilities.

microbiology↗

Genome-wide antibiotic-CRISPRi profiling identifies LiaR activation as a strategy to resensitize fluoroquinolone-resistant Streptococcus pneumoniae

Streptococcus pneumoniae is a human pathogen that has become increasingly resistant to the synthetic fluoroquinolone antibiotics that target bacterial topoisomerases. To identify pathways that are essential under fluoroquinolone stress and thus might represent novel targets to revitalize the use of this class of antibiotics, we performed genome-wide CRISPRi-seq screens to determine antibiotic-gene essentiality signatures. As expected, genes involved in DNA recombination and repair become more important under fluoroquinolone-induced DNA damage, such as recA, recJ, recF, recO, rexAB and ruvAB. Surprisingly, we also found that specific downregulation of the gene encoding the histidine kinase liaS caused fluoroquinolone hypersensitivity. LiaS is part of the LiaFSR (VraTSR) three-component regulatory system involved in cell envelope homeostasis. We show that LiaS keeps the response regulator LiaR inactive, and that deletion of liaS causes hyperphosphorylation of LiaR and subsequent upregulation of the LiaR regulon. RNA-seq was used to refine the LiaR regulon, highlighting the role of the heat-shock response and the pleiotropic regulator SpxA2 in fluoroquinolone sensitivity. Activating the LiaR-regulon by the cell envelope-targeting antibiotic bacitracin synergized with ciprofloxacin and levofloxacin. This synergistic antibiotic combination restored sensitivity in fluoroquinolone-resistant strains in vitro. Importantly, bacitracin/levofloxacin combination therapy was also effective in vivo and improved the treatment of fluoroquinolone-resistant S. pneumoniae infection in a zebrafish meningitis model. Together, the approaches and findings presented here provides a starting point for identification and validation of potent combination therapies that could be used in the clinic to treat antibiotic-resistant pneumococcal infections.

microbiology↗